weight loss drugs glp-1 Unlocking The Power of For What Are the Side Effects

doi: 10.3390/molecules27134315, 14

MacIsaac RJ, Ekinci EI, Jerums G

The cagrilintide injection is administered subcutaneously, once weekly, at any time of day regardless of meals

It could aid individuals with obesity or associated health issues

Methods Peptide therapy Synthetic KBP-089 (American Peptide Company, CA, USA) and liraglutide (SynPeptide, Shanghai, China) were dissolved in saline for subcutaneous delivery

While the complete results of the study have not yet been published, an initial press release in 2024 indicated that tirzepatide reduced the relative risk for the composite endpoint (HF urgent visit or hospitalization, oral diuretic intensification, or cardiovascular death) by 38%